Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > FULL FDA approvals cost 100's of millions at the ....
View:
Post by SouthernTierTom on Dec 31, 2021 9:14am

FULL FDA approvals cost 100's of millions at the ....

"end of the day" ....

Believing you are going to locate the "holy grail" ( FDA approval ) spending peanuts is a "naive thought" ( IMHO )

It takes money to get to the finish line, it is a rather simple concept.

My experience is that the more "focussed" the funding, the better chance of success...pour example "are financing taken or simply sold to the public at elevated prices"?

Watch and learn...

AND alway do your own due diligence and consult a professional on any money matter > $100 CAD or USD.  The internet is NOT the place to get advice. IMHEO

FWIW
Comment by CAinPlap on Dec 31, 2021 10:20am
I asked you previously what the future trial costs that we are likely to incur that would cost us these 100's of millions you so freely bandy about as a probability. I guess you missed that one as I never read your response. Or could it be that you are trying to instil a little fear and doubt? Are you sure you are not a member of those beech boys you so fondly refer to? Nah, you wouldn't ...more  
Comment by SouthernTierTom on Dec 31, 2021 10:20am
I thought maybe the "lack of response was due to ALL the faux cries of me being on "IGGY" ( TM Beech Boys ; - )  ) ....BUT then I noticed 140 READS and notta on comment... The post below is NOT meant to mislead, but rather to have a meaningful discussion around "funding" past, present and of course..."Future" Bueller?? ..anyone?? "end of the day" ...more  
Comment by CAinPlap on Dec 31, 2021 10:31am
I replied to your post and am eagerly waiting for you to reply to mine. As you are holding yourself out as someone knowledgable enuf on trial costs and financing to post about them, given TLT's current trial cost burn rate, what are the likely source of these 100's of millions in future expenses you are trying to make people believe we will or may incur? In the interests of not trying to ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250